Susan McMullen
Family Medicine · Gun Barrel City, TXNPI 1699758136
Payments from drug & device makers
Across 165 payments — averaging $18.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$421
- Pfizer$354
- Lilly USA, LLC$307
- AstraZeneca$303
- Novo Nordisk$268
- Otsuka America Pharmaceutical, Inc.$243
- plus $1K from 18 others
What the payments were for
- Food & beverage$3,119100%
- Education$120%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 21 | $421 |
| Pfizer | 14 | $354 |
| Lilly USA, LLC | 18 | $307 |
| AstraZeneca | 15 | $303 |
| Novo Nordisk | 16 | $268 |
| Otsuka America Pharmaceutical, Inc. | 10 | $243 |
| Amgen | 12 | $210 |
| Exact Sciences | 11 | $158 |
| AbbVie | 9 | $156 |
| Boehringer Ingelheim | 9 | $142 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $123 |
| Dexcom, Inc. | 6 | $110 |
| Mylan Specialty L.p. | 4 | $63 |
| Ardelyx, Inc. | 2 | $54 |
| Johnson & Johnson | 2 | $39 |
| Antares Pharma, Inc. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $25 |
| Bayer | 1 | $23 |
| Tactile Systems Technology Inc | 1 | $21 |
| Amneal Pharmaceuticals LLC | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Novartis | 1 | $13 |
How this compares
$3,131 in reported general payments places this provider in the 80th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 199 | $244,546 |
| TrulicityDulaglutide | 165 | $223,684 |
| OzempicSemaglutide | 180 | $207,197 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 200 | $196,804 |
| EliquisApixaban | 143 | $187,666 |
| Tresiba Flextouch U-100Insulin Degludec | 97 | $91,635 |
| MounjaroTirzepatide | 68 | $89,087 |
| JanuviaSitagliptin Phosphate | 57 | $71,738 |
| LinzessLinaclotide | 73 | $68,163 |
| XareltoRivaroxaban | 45 | $65,673 |
| ProliaDenosumab | 29 | $50,832 |
| Tresiba Flextouch U-200Insulin Degludec | 34 | $41,200 |
| TradjentaLinagliptin | 44 | $38,638 |
| FarxigaDapagliflozin Propanediol | 28 | $29,414 |
| MyrbetriqMirabegron | 35 | $28,970 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat, Spiriva Respimat, Stiolto Respimat | $142 | $324,876310 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $307 | $312,771233 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $421 | $230,879252 claims |
| Novo NordiskOzempic | $268 | $207,197180 claims |
| PfizerEliquis | $354 | $187,666143 claims |
| Johnson & JohnsonXarelto, Invega Sustenna | $39 | $89,80657 claims |
| AbbVieLinzess, Synthroid | $156 | $80,364191 claims |
| AstraZenecaFarxiga, Symbicort, Breztri Aerosphere | $303 | $61,17694 claims |
| AmgenProlia | $210 | $50,83229 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $243 | $28,87120 claims |
| Amneal Pharmaceuticals LLCRytary | $17 | $20,47119 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Gun Barrel City
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.